Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_885_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
34 Мб
Скачать
138 D. Lollar
there was a trend for survival benefit in the less severe group (mortality
26.5% with vasopressin versus 35.7% in norepinephrine group).
In patients with shock secondary to heart failure, inotropes to support cardiac
functions should only be used when blood pressure is insufficient. In this case, inotropes should only be started in patients with signs of volume over­load and inadequate cardiac function. Guidelines from the American College of Cardiology and the American Heart Association [J Am College Cardiology 2009; 53(15) e1–e90] do not advise use of any one agent or combination of agents for this purpose. However, Levy et al. (Crit Care Med 2011; 39: 450–455) published a randomized controlled trial of 30 patients compar­ing epinephrine to norepinephrine plus dobutamine in patients with non-ischemic heart failure (cardiac index < 2.2 L/min and mean arterial pres­sure < 60 mmHg) resistant to dopamine plus dobutamine. While both groups were able to attain goal hemodynamics (MAP > 65 mmHg), the epinephrine group had higher rates of arrhythmias and higher lactate levels. Additionally, the epinephrine group demonstrated decreased microcircular perfusion based on tonometry of the gastric mucosa.
Chapter 5-(vi)
Dysrhythmias
Jennifer A. Salotto, MD*
* Fellow, Trauma and Acute Care Surgery, Denver Health Medical Center
Take Home Points
Cardiac arrhythmias occur due to a derangement in electrical impulse
initiation, conduction, or both within the heart.
In surgical patients, factors including volume overload, manipulation of the
heart, intra-atrial catheters, electrolyte imbalances, and excess sympathetic tone can predispose to arrhythmia. Underlying structural abnormalities of the heart, congestive heart failure, and coronary artery disease may also promote arrhythmia.
History and electrocardiography are essential in the evaluation of arrhythmia.
Bradycardias result when impulses fail to generate at the sinoatrial node or
when these impulses are blocked along their path to the ventricles. Common bradycardias include sinus bradycardia, sinus node dysfunction, and atrioven­tricular heart block.
Tachycardias are categorized by the location of the origin of the irregular
impulse — above the atrioventricular node ( supraventricular tachycardia) or
Contact information: Denver Health Medical Center, University of Colorado Health Sciences Center, 777 Bannock Street, MC 0206, Denver, CO 80204; Tel.: 857-928-4766, email: Jennifer.salotto@ucdenver.edu
139
140 J. A. Salotto
below the atrioventricular node (ventricular tachycardia). Common supraven­tricular tachycardias include atrial fibrillation, atrial flutter, and ectopic supraventricular tachycardia. Ventricular tachycardias include premature ventricular beats, ventricular tachycardia, and ventricular fibrillation. When sustained or hemodynamically significant, these entities require urgent inter­vention as they may lead to sudden death.
The impact of an arrhythmia will depend upon the ventricular response to the
arrhythmia, the ability to preserve cardiac output, and the degree of underlying structural or ischemic disease.
The foundation of therapy for arrhythmias includes antiarrhythmic drugs, car-
dioversion, defibrillation, and permanent implantable pacemaker/defibrillator devices.
Background
The conduction system of the heart
The sinoatrial node (SA node) is the physiologic pacemaker of the heart. It
generates the cardiac impulse and displays automaticity.
The sinus node lies at the junction of the superior vena cava and the right
atrium.
The artery supplying the sinus node branches from the right circumfl ex
coronary artery in 60% of people, and from the left circumfl ex coronary artery in 40% of people.
After conduction through the atria, electrical signals are transmitted to the
atrioventricular node (AV node). Transmission continues through the inter­ventricular septum via the Bundle of His, the right and left bundle branches, and then to the Purkinje fibers, which activate the ventricles.
 The AV node and the His-Purkinje system are both capable of pacemaker
activity. They can override the SA node if it is suppressed.
 The main function of the AV node is to control atrial impulse transmis-
sion to the ventricles, thus regulating the speed of atrial and ventricular contraction.
The cardiac conduction system is heavily innervated by the parasympathetic
and sympathetic nervous system. Heart rate and speed of conduction are determined by the relative degree of input from parasympathetic and sympa­thetic stimuli.
Dysrhythmias 141
 Parasympathetic innervation is supplied by the vagus nerve, which
releases acetylcholine. This neurotransmitter acts on muscarinic recep­tors to slow sinus node impulse generation and conduction through the AV node.
 Sympathetic stimulation causes epinephrine and norepinephrine to act on
adrenergic receptors. The result is faster conduction and increased impulse generation by the SA node.
Cardiac electrophysiology and understanding the electrocardiogram
The P wave on an electrocardiogram (EKG) represents atrial depolarization.
The PR interval is the time from the beginning of the P wave to the beginning
of the Q wave, the length of which depends on the conduction velocity through the AV node. A slower conduction means a lengthened interval.
The QRS complex represents the depolarization of the ventricle.
The QT interval is the interval from the beginning of the Q wave to the end of the T
wave. The QT interval represents depolarization and repolarization of the ventricle.
The ST segment is the end of the S wave to the beginning of the T wave. The
T wave represents ventricular repolarization, when the ventricle relaxes and prepares for another contraction.
Main Body
Arrhythmia in the postoperative period
Postoperative arrhythmias are very common after both cardiac and non-car-
diac surgery.
Baseline patient characteristics which can contribute to arrhythmia include
structural abnormalities of the heart (for example, prior scarring after myocar­dial ischemia), cardiomyopathy, congestive heart failure, and coronary artery disease.
Iatrogenic factors which promote arrhythmia include cardiopulmonary
bypass, manipulation or direct injury of the heart, certain drugs, and intra­atrial catheters.
Characteristics of the postoperative state including metabolic and electrolyte
imbalances, hypoxemia, excess sympathetic tone from pain or stress, and volume overload all predispose the postoperative patient to arrhythmia.
142 J. A. Salotto
The evaluation of a patient with an arrhythmia
Begin with a thorough history and physical exam.
 Ask about family history of arrhythmias or sudden cardiac death, ischemic
or valvular heart disease, and recent medications.
 A review of systems should include questions regarding chest pain, short-
ness of breath, a feeling of skipped heartbeats or palpitations, presyncope (dizziness, lightheadedness, feeling faint), or syncope. These symptoms may accompany any of the arrhythmias.
 Try to determine factors which may precipitate or terminate the symp-
toms. For example, are symptoms relieved with breath-holding or the Val­salva maneuver? This would indicate a problem at or above the AV node (a supraventricular tachycardia).
Physical exam
 Begin by assessing if the patient is hemodynamically stable or unstable,
and address the fundamentals of airway, breathing and circulation. Ensure adequate intravenous access.
 Assess mentation, ability to protect the airway, pulse rate, blood pressure,
distal perfusion, and consider any underlying ischemia or congestive heart failure. Ensure that the patient is monitored with telemetry and continuous pulse oximetry.
The urgency of therapy depends on hemodynamic stability.
If the patient is symptomatic from a bradycardia, call for a transcuta-
neous pacer.
If the patient has lost consciousness and the monitor demonstrates a
wide QRS complex, call for an electrical defi brillator.
 If the patient is stable and the monitor demonstrates a rapid, narrow QRS
complex with P waves, consider supraventricular tachycardia as the diagno­sis. In this situation, vagal maneuvers should be attempted (see below).
Progress from simple, less invasive testing to more complex testing. The
first-line in diagnosis is electrocardiography (EKG).
 Look for the presence of P waves. If P waves are not visible, suspect atrial
fi brillation. An atrial rate around 300 beats per minute suggests atrial fl ut­ter. In atrioventricular block, there are more P waves than QRS complexes — the sinoatrial node is fi ring but the signal is not conducting to the ven­tricles.
Dysrhythmias 143
 A wide QRS complex is seen with ventricular tachycardias and also with
supraventricular tachycardias with a bundle-branch block or an accessory pathway.
Early in the evaluation of an arrhythmia, be sure to address any underlying
abnormalities which may be triggering the arrhythmia, including ischemia, hypercarbia, proarrhythmic drugs, electrolyte imbalances, volume overload, or a catheter which is placed too far into the right atrium.
Another tool used in the evaluation of an arrhythmia is an echocardiogram.
This will evaluate for functional and structural abnormalities which may pre­dispose to arrhythmia, and is especially recommended for those with ventricular arrhythmias.
Finally, invasive electrophysiological testing can give more information.
Cardiologists usually recommend this for those with a history of myocardial infarction and ventricular tachyarrhythmia prior to ablation, for those with syncope and impaired LV function or for those with structural heart disease.
Bradyarrhythmias
Bradyarrhythmias are usually due to SA node dysfunction (failure to initi-
ate an impulse) or an AV conduction block (failure of conduction) which results in a heart rate less than 60 beats per minute. Bradyarrhythmia can represent a response to a medication, or it may be physiologic and present at baseline.
Common bradyarrhythmias in the postoperative period include sinus brady-
cardia, bradycardia from sinus node dysfunction, and the AV nodal heart blocks.
Bradyarrhythmias are commonly asymptomatic, but if cardiac output fails to
meet physiologic demands, symptoms can result. Despite a low heart rate, cardiac output and oxygen delivery can be preserved if the heart is able to compensate with an increase in stroke volume.
Physiologic sinus bradycardia is caused by depressed automaticity in the SA
node. Sinus pauses up to 3 seconds or a heart rate as low as 30 beats per min­ute can be considered in the normal range if the patient is asymptomatic. Sinus bradycardia is common in healthy athletes and during sleep. Bradycardia may be present during periods of hypoxia in patients with obstructive sleep apnea.
 Symptoms include syncope, pre-syncope, fatigue, hypotension, and weak-
ness.
144 J. A. Salotto
Bradycardia from sinus node dysfunction is often referred to as “sick sinus syn-
drome.” This entity is caused by abnormalities in the sinus node which lead to disorders in atrial impulse formation and conduction. It may be caused by fibro­sis of the SA node, most commonly from inflammation, infection, aging, surgical trauma, or infarction. Less commonly, sick sinus syndrome may be caused by infiltrative diseases, increased vagal tone, or collagen vascular diseases.
 Extrinsic causes of sick sinus syndrome include medications like beta-
blockers, calcium channel blockers, and digoxin, electrolyte abnormali­ties, excess intracranial pressure, hypothermia, and hypothyroidism.
 An EKG demonstrates bradycardia, sinus pauses, or transient sinus arrest.  Sick sinus syndrome is a common cause for pacemaker implantation.
Bradycardia from atrioventricular conduction disturbances are commonly
known as atrioventricular block. AV block results from delayed conduction through the atrioventricular node or through the His bundles. It may be sec­ondary to fibrosis of the pathway, an electrolyte imbalance, an endocrine disorder, or drugs. The etiology is similar to that causing sinus node dysfunc­tion (fibrosis, inflammation, aging, etc.) A myocardial infarct in the distribution of the right coronary artery may cause transient AV block.
 First degree AV block is slowed conduction through the AV junction. The
PR value is greater than 0.2 seconds, with every P wave followed by a QRS complex. The ratio of atrial to ventricular contractions is maintained at 1:1.
 Second degree AV block occurs when the atrial rhythm fails to conduct in
a 1:1 ratio, but some transmission is maintained.
Mobitz type I (Wenckebach) will demonstrate a stable PP interval, a
shortening of the RR interval, and progressive prolongation of the PR interval until one P wave fails to conduct on an EKG.
Mobitz type II will demonstrate a stable PR interval with no predict-
able prolongation of the PR interval and random failure of P wave conduction on EKG.
Second degree, high grade AV block is any conduction ratio of over 3:1.
 Third degree AV block is known as complete heart block, and represents a
complete dissociation between atrial and ventricular activity.
The treatment of symptomatic bradycardia depends on the presence or
absence of symptoms and hemodynamic stability.
Dysrhythmias 145
 No treatment is needed for asymptomatic bradycardia, unless the etiology
is third degree heart block.
 Correct electrolytes and withhold any medications which block the AV
node.
 For symptomatic bradycardia leading to hypotension, altered mentation,
chest pain, or shock, give atropine 0.5 mg intravenously every 3–5 minutes up to a total does of 0.04 mg/kg. This should be done in a monitored set­ting.
 Initiate transcutaneous pacing if the arrhythmia is refractory to atropine.
Place pads anteriorly over the apex of the heart and posteriorly be-
tween the spine and the scapula.
Transcutaneous pacing is effective but uncomfortable to the patient.
 Initiate transvenous temporary pacing if the patient requires pacing for
longer than a few minutes.
 A permanent pacemaker is indicated for ongoing symptomatic SA
dysfunction, severe symptoms related to bradycardia, Mobitz type II second degree or any third degree heart block, and symptomatic brady­cardia with atrial fi brillation. After myocardial infarction, a persistent second or third degree heart block (especially if symptomatic) or any AV block associated with a bundle branch block should be treated with pacemaker.
Tachyarrhythmias
Tachycardias are categorized by where the irregular impulse originates, either
above the atrioventricular node (supraventricular tachycardia) or below the atrioventricular node (ventricular tachycardia). Tachyarrhythmia implies a rhythm that produces a heart rate greater than 100 beats per minute.
Symptoms may include dyspnea, palpitations, dizziness, chest pain, or
syncope. Hemodynamic compromise may result.
Supraventricular Tachycardia
 In supraventricular tachycardia, an impulse arises above the bundle of His
and leads to a heart rate greater than 100 beats per minute. In postoperative patients, the most common of these arrhythmias include atrial fi brillation, atrial fl utter, and ectopic supraventricular tachycardia.
 Atrial Fibrillation
146 J. A. Salotto
Atrial fi brillation occurs when an impulse arises above the bundle of
His which results in disorganized atrial activity and a dyssynchrony of contraction of the atrium and the ventricle. Because contraction is not coordinated, this causes loss of the “atrial kick” which in turn reduces cardiac output. In those with poor heart function or little reserve, this may lead to unstable hemodynamics. Stasis of blood in the heart can lead to thromboembolic events.
Atrial fi brillation is the most common postoperative arrhythmia. Onset
usually occurs within 4 days of surgery.
The hallmark of atrial fi brillation on EKG is a loss of P-waves. Atrial
activity is rapid and disorganized, with an unpredictable ventricular response.
Complications of atrial fi brillation include increased costs, longer hos-
pital stays, and an increased risk of thromboembolic events after 24 to 48 hours.
The most important risk factor for the development of atrial fi brilla-
tion after surgery is age over 60 years old. Other risk factors include male gender, congestive heart failure, and valvular disease. Surgeries including esophagectomy, pulmonary resection, intra-abdominal sur­gery, and vascular surgery all carry an increased risk of postoperative atrial fi brillation.
Most postoperative atrial fi brillation is transient and often requires no
therapy. Of those who do not resolve spontaneously, the majority will re­solve with pharmacologic rate or rhythm control during hospitalization.
Therapeutic intervention should be initiated for those with heart
failure, atrial fi brillation lasting over 48 hours, uncontrolled ven­tricular rates, and a history of prior stroke. Before initiating therapy, ensure correctable etiologies such as electrolyte imbalance or volume overload have been addressed.
The pillars of treatment for atrial fi brillation are rate control and
rhythm control.
Rate control slows the ventricular response to atrial fi brillation, allow-
ing for improved ventricular and coronary fi lling and improved cardiac output. This is a good choice for early (<24 hours) postoperative atrial fi brillation.
Beta-blockers
 Beta-blockers are safe and effective agents which have direct antiarrhyth-
mic activity on conduction cells and myocardial cells. They counteract the
Dysrhythmias 147
hyperadrenergic state of the postoperative period and have been shown to accelerate conversion to sinus rhythm in comparison to calcium channel blockers.
 Recommended agents:
Esmolol (500 mcg/kg IV over 1 minute loading dose, then 50 mcg/kg/
minute IV drip).
Metoprolol (5 mg over 3–5 minutes, up to 3 doses, followed by 5 mg
IV every 6 hours).
 Contraindications: hypotension, bradycardia, heart block, decompensated
Calcium channel blockers (CCBs)
 CCBs are recommended as second-line therapy for rate control, or as fi rst-
line in patients who cannot tolerate beta-blockers. They provide a strong blockade of the calcium channel in the AV node which leads to slowed impulse conduction.
 One study by Siu et al. showed superior time to ventricular rate control
and symptom control with diltiazem when compared to amiodarone or digoxin.
 Recommended agents:
Verapamil (5–10 mg over 3-5 minutes, followed by 2.5–10 mg mainte-
nance dose)
Diltiazem (0.25 mg/kg over 3–5 minutes for maximum of 20 mg, fol-
lowed by 5–15 mg/hour maintenance dose).
 May result in hypotension.
Amiodarone
 A good choice for ventricular rate control in atrial fi brillation in those with
heart failure and in those who are hemodynamically unstable.
 Must be used under monitoring as side effects may include sinus brady-
cardia, AV block, respiratory dysfunction, and hypotension. For these rea­sons, not a great fi rst-line agent in stable patients.
 Dose: 15 mg/min for 10 minutes, then 1 mg/min for 6 hours; follow with
maintenance dose of 0.5 to 1 mg/minute.
Digoxin works indirectly by increasing parasympathetic stimulation to the
heart. This may not be enough to counteract the excess sympathetic stimula­tion found in a surgical patient. It is a good agent to use in heart failure.